Forte Biosciences Inc (FBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Operating Expenses | 24,571 | 18,383 | 11,579 | 16,124 | 7,351 |
| Operating Income | -24,571 | -18,383 | -11,579 | -16,124 | -7,351 |
| Other Income | 820 | 701 | 330 | 468 | 196 |
| Pre-tax Income | -23,751 | -17,682 | -11,249 | -15,656 | -7,155 |
| Net Income Continuous | -24,788 | -17,682 | -11,249 | -15,656 | -7,155 |
| Net Income | $-24,788 | $-17,682 | $-11,249 | $-15,656 | $-7,155 |
| EPS Basic Total Ops | -1.39 | -0.99 | -0.96 | -1.37 | 3.18 |
| EPS Basic Continuous Ops | -1.39 | -0.99 | -0.96 | -1.37 | 3.18 |
| EPS Diluted Total Ops | -1.39 | -0.99 | -0.96 | -1.37 | 3.18 |
| EPS Diluted Continuous Ops | -1.39 | -0.99 | -0.96 | -1.37 | 3.18 |
| EPS Diluted Before Non-Recurring Items | -1.45 | -0.99 | -0.96 | -1.37 | N/A |
| EBITDA(a) | $-24,543 | $-18,372 | $-11,804 | $-16,111 | $-7,497 |